GH1 and acromegaly: Therefore, the aim of the present study was to investigate patient characteristics as well as occurrence of fractures and potential influencing factors in a large cohort of adult GHD patients with previous CD, acromegaly and nonfunctioning pituitary adenoma (NFPA), respectively, at the start of and during long-term GH replacement therapy.